Approach to the treatment of cutaneous malignancy in HIV-infected patients.
Patients infected with human immunodeficiency virus (HIV) have an increased risk of developing skin cancers. These at-risk patients may have atypical presentations and/or altered clinical courses. This article will review and discuss management issues for the following malignancies: lymphomas, malignant melanoma, basal cell carcinoma, squamous cell carcinoma, and Kaposi's sarcoma.
Wilkins
Karl
K
University of California, San Francisco, USA. kwilkins@itsa.ucsf.edu
Dolev
Jacqueline C
JC
Turner
Ryan
R
LeBoit
Philip E
PE
Berger
Timothy G
TG
Maurer
Toby A
TA
D002280:Basal Cell Carcinoma / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008223:Lymphoma / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D008545:Melanoma / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D012514:Sarcoma, Kaposi / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D012878:Skin Neoplasms / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*